MedTrace Logo

Diagnostic and Prognostic Blood Markers in Non Specific Low Back Pain

NCT05751499 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-07-27

No results posted yet for this study

Summary

• To compare the diagnostic and prognostic blood markers in acute and chronic nonspecific low back pain with healthy controls

Conditions

  • Low Back Pain

Interventions

DIAGNOSTIC_TEST

• Blood Markers CRP, TNFα, IL-6, IL-8, IL-1, and IL-1β AND FIBRINOGEN

* Low Back Outcome Scale * Center for Epidemiological Studies-Depression Scale (CES-D) * International Physical Activity Questionnaire * Roland-Morris Disability Questionnaire * Force Platform * Pain Self-Efficacy Questionnaire (PSEQ) * Numeric Rating Scale * Job Content Questionnaire * Pits Burgh Sleep Quality Index (PSQI) * Orebo Musculoskeletal Pain Screening Questionnaire * Gait \& Balance App * Keele STarT Back Screening Tool (SBST) * Fear-Avoidance Beliefs Questionnaire (FABQ) * Pain Catastrophizing Scale

Sponsors & Collaborators

  • KRL Hospital, Islamabad

    collaborator OTHER

  • Riphah International University

    lead OTHER

Principal Investigators

  • Waqar A Awan, PhD · Faculty of Rehabilitation & Allied Health Sciences, Riphah International University

  • IMRAN AMJAD, PhD · Riphah International University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-04-30
Completion
2024-05-31
FDA Device
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05751499 on ClinicalTrials.gov